skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Two weeks ago I asked the following question below.

Can you please confirm that you meant Trane Technologies and not The Trade Desk. I know that the Trade Desk seems to be one of your favourites. Thank you.

Question:
We are looking to adds some US positions to our TFSA. We currently have AMD, DAL, DOCU, BRK-B, and ROKU. Could you suggest 5 growth names for long term holds that you would feel comfortable entering new positions in today? And would you add to ROKU at present? Thanks in-advance.

Answer:
We still like ROKU and thing it can move more. But we would keep weighting/risk in mind. It is the type of stock that moves quickly (both ways). We would suggest: CRWD, NVDA, VEEV, U, TT

Read Answer Asked by Stefan on December 15, 2020
Q: Can you please comment on the Emerge ARK ETFs? I love that the ARK ETFs are available in $C but am concerned that 1) the listings are on the NEO, 2) their traded volume is quite low and 3) their return is already a few percent behind that of the real (US) ARK ETFs. Thanks.
Read Answer Asked by Michael on December 15, 2020
Q: Which company in the U.S. is equivalent to Interac here in Canada?
Thanks
Read Answer Asked by Curtis on December 15, 2020
Q: THRM can you take a look at this penny stock .... it reads like a real potential success story ....
Read Answer Asked by Bob on December 15, 2020
Q: Could I have your thoughts on BioHaven. It has a new drug for acute treatment of migraine headaches and seems to be very effective. Their stock has progressed since the drug was first put on the market earlier this year. How do they look financially? I believe they have an interest in another company Kleo Pharmaceuticals. I believe The Bill & Melinda Gates Foundation has also given Kleo a substantial grant.
Thanks John
Read Answer Asked by John on December 15, 2020
Q: I'm planning to enter a position to buy GC. I figure that even if Apollo's buyout deal falls through, GC is still likely to be a good hold for the next few years. Apollo's offer of $39/stock in the middle of the pandemic is a low-offer - I think that after the COVID vaccine has been distributed, GC's income will normalize and the stock price will be worth more than the offer price. I'd like your thoughts as to whether my logic is sound and without too much emotion. Thanks
Read Answer Asked by Esther on December 15, 2020
Q: Hello Peter, assuming an already have a diversified portfolio, in what order would you choose the following for long-term wealth creation (whether from dividends or gains): ETSY, PINS, SQ, NVDA, LSPD, ADBE, ARKW, MKP. Thank you.
Read Answer Asked by James on December 15, 2020
Q: 2 recent purchases of mine SNOW which is falling faster than the snow outside, and NXPI I am under water since the day after I bought it (3 days ago), now Goldman Sacks has downgraded the stock - your opinion and SNOW was also falling on after hours trading below what it closed at 4 o'clock - appreciate your input on these 2 cases. Thanks,
Read Answer Asked by Dennis on December 15, 2020
Q: Current assessment of these two stocks. Mdf had a big jump today on the Aldi News. Would you recommend either of these 2 at current price.

For XBC the stock has run up a fair bit. Would you recommend a buy here or wait for a pullback
Read Answer Asked by Aleem on December 15, 2020
Q: Fast forward 2 years from today, and assume a return to something that resembles normal.
Which stocks (US and CA) would you wish you bought today.
Read Answer Asked by Gregory on December 15, 2020
Q: Hi Peter, Ryan and team,

There are 8 stocks in my TFSA. REAL is 5% and LSPD also is 5% of the value of my TFSA. Which of the 2 stocks do you think I should buy more of?

A more broader question, is 8 stocks in a TFSA too many? Should I try to amalgamate to 5-6 stocks?

Thanks.
Read Answer Asked by Marvin on December 15, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!